JP Morgan Chase’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.7K | Sell |
41,987
-68,386
| -62% | -$57.7K | ﹤0.01% | 6383 |
|
|
2025
Q4 | $86.4K | Buy |
110,373
+4,556
| +4% | +$3.74K | ﹤0.01% | 5968 |
|
|
2025
Q3 | $76.3K | Buy |
105,817
+64,710
| +157% | +$293K | ﹤0.01% | 6056 |
|
|
2025
Q2 | $208K | Buy |
+41,107
| New | +$162K | ﹤0.01% | 5203 |
|
|
2025
Q1 | – | Sell |
-178,532
| Closed | -$646K | – | 7821 |
|
|
2024
Q4 | $646K | Buy |
178,532
+147,092
| +468% | +$445K | ﹤0.01% | 4908 |
|
|
2024
Q3 | $55.3K | Buy |
31,440
+10,754
| +52% | +$19.6K | ﹤0.01% | 5959 |
|
|
2024
Q2 | $32.3K | Sell |
20,686
-13,168
| -39% | -$22.9K | ﹤0.01% | 6016 |
|
|
2024
Q1 | $66K | Buy |
33,854
+21,987
| +185% | +$38.4K | ﹤0.01% | 5835 |
|
|
2023
Q4 | $16.7K | Sell |
11,867
-37,775
| -76% | -$48.5K | ﹤0.01% | 6292 |
|
|
2023
Q3 | $78.4K | Sell |
49,642
-9,657
| -16% | -$17.9K | ﹤0.01% | 5626 |
|
|
2023
Q2 | $128K | Sell |
59,299
-75,569
| -56% | -$165K | ﹤0.01% | 5347 |
|
|
2023
Q1 | $283K | Buy |
134,868
+132,271
| +5,093% | +$290K | ﹤0.01% | 4841 |
|
|
2022
Q4 | $6K | Buy |
+2,597
| New | +$6.12K | ﹤0.01% | 6140 |
|
|
2020
Q4 | – | Sell |
-6
| Closed | – | – | 5997 |
|
|
2020
Q3 | $0 | Buy |
6
+1
| +20% | +$4 | ﹤0.01% | 5842 |
|
|
2020
Q2 | $0 | Buy |
+5
| New | +$18 | ﹤0.01% | 5758 |
|
|
2018
Q1 | – | Sell |
-2,151
| Closed | -$105K | – | 5668 |
|
|
2017
Q4 | $105K | Buy |
2,151
+2,022
| +1,567% | +$124K | ﹤0.01% | 4647 |
|
|
2017
Q3 | $9K | Buy |
+129
| New | +$5.98K | ﹤0.01% | 4737 |
|
|
2016
Q3 | – | Sell |
-3,087
| Closed | -$120K | – | 4861 |
|
|
2016
Q2 | $120K | Sell |
3,087
-23,545
| -88% | -$1.09M | ﹤0.01% | 3847 |
|
|
2016
Q1 | $1.47M | Sell |
26,632
-207
| -0.8% | -$15.7K | ﹤0.01% | 2865 |
|
|
2015
Q4 | $3.69M | Buy |
26,839
+827
| +3% | +$118K | ﹤0.01% | 2407 |
|
|
2015
Q3 | $3.74M | Buy |
26,012
+12,708
| +96% | +$2.9M | ﹤0.01% | 2402 |
|
|
2015
Q2 | $3.45M | Buy |
+13,304
| New | +$4.13M | ﹤0.01% | 2611 |
|
Other funds holding ATYR
VCM
GCP
